based on sensors that either detect tremor or identify volitional movement. Wearable inertial or electromyography (EMG) sensors are both attractive options because of their ability to directly monitor a patient's limb movements. 5 Another potential signal source to determine when a patient will experience tremor is the motor cortex. 6 Betaband desynchronization in the motor cortex has long been known to be associated with intentional movement of the limb, and these signals can be clearly observed using either electroencephalography on the scalp 12 or electrocorticography (ECoG) on the brain surface. 3 Using either type of signal may permit systems to automatically determine when and how stimulation is needed, allowing the patient to experience side effects only while actually using his or her arm. Additionally, such systems may allow increased device battery life given the reduced amount of stimulation output.
To investigate the utility of both cortical neural sensing and dynamic stimulation adjustment in patients with ET, we implanted in a single ET patient a stimulation lead in the ventral intermediate nucleus of the thalamus (VIM) and a subdural electrode strip over the patient's motor cortex, connected to an Activa PC+S DBS generator. The Activa PC+S system is a Medtronic neurostimulator that can sense data from implanted electrodes. 10 The sensed data can be streamed to an external computer onto which they can be logged, control external devices, or trigger stimulation changes. In the following case report, we describe the patient's clinical data, his surgical outcomes, and the results from several preliminary experimental sessions with him. We demonstrate the system's sensing capability during movement tasks overtly performed and imagined. Using wearable inertial and EMG sensors on the tremoraffected arm, we then demonstrate the ability to deliver responsive closed-loop dynamic stimulation to treat tremor in a closed-loop fashion.
Case Report

History and Examination
A 58-year-old right-handed man presented to his neurologist with an action tremor noted for about 4 years. This tremor affected mainly his right upper and lower extremities with minimal left-sided symptoms and no head or voice tremor. Tremor was not present at rest and worsened with intentional movement. The patient did not have any history suggestive of rapid eye movement (REM) sleep behavior disorder, constipation, postural dizziness, or gait or balance problems. He had had no exposure to dopamine antagonists. His tremor became more severe over 2 years, which significantly impacted his activities of daily life, particularly when eating and drinking. The patient did not drink alcohol and did not notice that alcohol improved his tremor. His family history was unknown as he was adopted. Propranolol did not have significant benefit, and a trial of primidone was not tolerated because of side effects.
On neurological examination, his affect and speech were normal. He scored 29/30 on the Montreal Cognitive Assessment (MoCA). He had no hypomimia or hypophonia. Cranial nerves II-XII were intact. He had no motor or sensory deficits. He had no ataxia. Rapid alternating movements were normal and symmetric. Gait and arm swing were normal; he rose from a chair briskly without using his arms. He independently recovered with 1 step on the retropulsive pull test.
Presurgical Evaluation
The patient had no head or voice tremor and no tremor at rest. His tremor on the right side was evaluated to be severe during action and while holding posture. On the left side, there was minimal to no tremor. The Fahn-TolosaMarin Tremor Rating Scale (TRS) was used to evaluate tremor severity preoperatively (scores: Part A, 13; Part B, 10; Part C, 10). Preoperative gait and balance evaluations were performed, with no fall risk identified on the Berg Balance Test (55/56), 10-Meter Walk Test (1.6 m/ sec), and Dynamic Gait Index (22/24). Preoperative and perioperative imaging revealed no concerning anatomical lesions. A DaTscan (GE Healthcare) showed no evidence of nigrostriatal degeneration. Magnetic resonance images obtained for operative planning included a 3-T volumetric T1 magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence (1.5-mm slice thickness, 512 × 512 matrix, FOV 250).
Operative Procedure
Surgical treatment options were discussed with the patient, and informed consent for implantation of the DBS system targeting the left VIM was obtained. Separately, in accordance with institutional review board and Investigational Device Exemption regulations, research staff approached the patient, and he was enrolled in this study.
The patient was brought to the operating room and intravenous sedation was initiated. He was positioned supine, and his head was placed in 3-point fixation using a skull clamp and long Doro Transitional Member Radiolucent headrest system (Pro Med Instruments GmbH) after infiltration of the pin sites with a local anesthetic. Bone fiducials (Medtronic Inc.) were affixed to the skull, and an intraoperative CT scan (1.25-mm slice spacing, 512 × 512 matrix, FOV 250) was obtained using the CereTom scanner (NeuroLogica Inc.). The CT and MRI studies were merged using FrameLink (Medtronic Inc.), and an operative plan targeting the left VIM was created. The hand motor cortex was identified anatomically, and scalp overlying this target was marked in indelible marker.
Electrode placement was performed using the NexFrame frameless stereotactic system (Medtronic Inc.), as previously described, 2 with the following modifications. After securing the Stimloc bur hole cover (Medtronic Inc.) to the skull and before placement of the NexFrame base, the dura mater was opened widely in a cruciate fashion. A Resume II electrode (model 3587, Medtronic Inc.) was introduced into the subdural space directed toward the hand motor cortex. The hand motor cortex was localized using anatomical landmarks on MRI. The central sulcus was located using axial and sagittal views. The cortical electrode was manipulated to straddle the central sulcus at the level of the "hand knob" on MRI, and additional CT scanning was performed to confirm this localization. The spacing of the distal contacts on the Resume II electrode is not compatible with our standard cables for testing somatosensory or motor evoked potentials, and this testing was not performed. A channel was drilled into the Stimloc bur hole cover for egress of this electrode. The thalamic lead (model 3387, Medtronic Inc.) was then placed at the target. An intraoperative CT was obtained to confirm the location of the thalamic electrode and cortical strip. Vector error to target was 0.3 mm for the thalamic electrode. Cortical electrodes were adjusted such that 2 contacts were situated over presumed hand motor cortex and 2 were over hand sensory cortex. The final locations of the implanted electrodes for cortical sensing and VIM stimulation are shown in Fig. 1 .
The patient was allowed to awaken for macroelectrode stimulation testing. He exhibited a robust microlesion effect with nearly complete extinction of tremor. Testing for side effects with bipolar stimulation (Contact 0-3+, pulse width 90 msec, rate 130 Hz) showed none up to an amplitude of 4.0 V, when transient paresthesias were noted. At 5.0 V, the patient exhibited mild dysarthria. He was reanesthetized, electrodes were secured, and closure of soft tissues proceeded in a standard fashion.
One week later, the patient underwent implantation of the Activa PC+S generator (Medtronic Inc.) while under general anesthesia, without complication. This is an experimental device with limited availability from Medtronic under an Investigational Device Exemption from the Food and Drug Administration. Externally, it is identical to the dual-lead Activa PC. However, this device has the capability to acquire electrophysiological data as well as provide clinical DBS. It is programmable with the Medtronic 8840 clinical programmer but has the capability to store limited amounts of electrophysiological data, as well as stream these data in real time via the Nexus-D (Medtronic Inc.), which allows bidirectional communication between the PC+S pulse generator and a computing system via Universal Serial Bus (USB) connection.
Postoperative Course
At the patient's first postoperative visit 2 weeks after generator implantation, he continued to show a microlesion effect but with minimal return of tremor. Monopolar mapping was performed, with no lasting side effects seen with stimulation up to 4.0 V (pulse width 90 msec, rate 130 Hz). Six weeks after surgery, the device was programmed with the following settings: electrode configuration 2+1−, pulse width 90 msec, rate 130 Hz, amplitude 3.7 V. When he returned 10 weeks postoperatively, he noted transient paresthesias when the system was turned on and off. The device was reprogrammed to his current settings, with an electrode configuration of 2+1−, pulse width 90 msec, rate 150 Hz, and amplitude 2.5 V. His TRS scores with stimulation have greatly improved (Part A: 1, Part B: 3). Figure 2 illustrates the benefit this patient receives from DBS during a standard spiral drawing task. As can be seen, there is a marked difference in his ability to draw spirals between the stimulation off and on states.
Sensing of Actual and Imagined Movements
To characterize signals recorded from the cortical electrodes during periods of movement and intention, we designed a task in which a computer prompted the user to move his arm or hand or to rest while we measured the limb activity using a worn accelerometer. We prompted the patient to alternate between movement and rest every 3 seconds to collect 20 trials each of arm and hand movements and 40 trials of rest. The patient was then asked to only imagine the movements of the same tasks, and the worn accelerometer was used to confirm that they did not accidentally perform actual movements. During both trials the Medtronic Nexus-D system was used to stream data from the Activa PC+S to a laptop at which it was time-stamped and logged. The Activa PC+S sensing lead was configured to record data sensed differentially from the hand M1 to S1 cortex sampled at 422 Hz. It is important to note that the patient did not experience tremor while performing any of the prompted movements. Example time-series plots of the raw data collected from these trials are displayed in Fig. 3 for both actual and imagined movement experiments.
We then segmented the data into periods based on the prompted action. The power spectral density (PSD) was calculated for each prompted action using Welch's method with a 512-sample-long Hann window with 80% overlap. The output PSD was then averaged with the other trials with the same prompted action to generate an average PSD for a given state. These average PSD plots are displayed in Fig. 4 for both the overt and imagined movement tasks. Since the patient often took some time to react to the prompt and change his limb's state, the PSDs excluded the 1st second of every prompted action.
As can be seen in the overt movement PSD plots in Fig. 4 , the cortical signal's beta band is desynchronizing as expected whenever the patient moves his limb. During rest, the patient seems to have beta peaks at both 20 and 32 Hz. The beta-band power during overt arm and hand movements illustrates a broad drop in band power across the entire band, with a more pronounced beta-band desynchronization occurring during hand movement. However, for imagined movement, only a small band around the 32-Hz peak lowered on average during the prompted imaginary actions, but the results were so variable that it was difficult to distinguish between resting and imagined movement.
Closed-Loop DBS With Wearable Inertial and EMG Sensors
To demonstrate CLDBS using this system, we asked the patient to move his hand from his lap and to hold it in front of his nose. This task consistently evoked tremor in the stimulation-off state. We collected inertial and EMG data from the shaking limb while he performed this action and used the sensed data to trigger stimulation changes in real time. The inertial measuring unit (IMU) we used was an Android smartwatch with a custom application sampling the on-board accelerometer and gyroscope at 100 Hz. The EMG system used was a gTec Mobilab, which uses active electrodes and samples data at a 256-Hz rate. For the first system, we used the inertial sensor to deliver stimulation based on the presence of tremor. The system would increase or decrease stimulation based on the magnitude of the tremor band power between 4 and 8 Hz on the 3 gyroscope channels. This band was chosen because the patient's primary tremor frequency was around 5 Hz. For the second system, we used EMG to trigger stimulation changes whenever the patient volitionally moved his limb. To accomplish this we attached 4 EMG electrodes to the patient's arm (bicep, triceps, anterior forearm, posterior forearm) and triggered stimulation whenever the total EMG band power (4-50 Hz) summed to a value larger than a calibrated threshold. The experimental results of the patient's responses while using these systems are shown in Fig. 5 .
The plot is separated into 4 distinct system states: no stimulation, open-loop stimulation, IMU tremor-modulated stimulation, and EMG movement-triggered stimulation. As can be seen in the gyroscope magnitude plot, there are large peaks whenever the patient started or stopped movement, which carries over into the 4-to 8-Hz band power plot. These artifacts are caused by the cross-band frequency components of initiating movement and the arm impacting the lap when the task was complete. To remove these artifacts and determine a quantified estimate of the actual tremor the patient was experiencing, we multiplied the tremor band power by the proportion of the tremor band over the total band power. This takes advantage of the large cross-band nature of the artifact and results in good removal of the initiation and impact events, as can be seen in the tremor intensity plot.
With a quantified estimate of the tremor throughout the trial, we can assess the amount of tremor the patient experiences while performing the limb movement in each of the 4 states. The quantifiable metrics of tremor and power usage during the open-loop, tremor-modulated, and movement-triggered trials are compiled in Table 1 . The tremor experienced by the patient in each state is normalized to the open-loop tremor. The stimulation power difference is determined by comparing the closed-loop stimulation power with the open-loop settings. The final column represents the trade-off between power and any additional tremor the patient would experience while using the closed-loop system as compared with the open-loop version. The rationale and methods for these CLDBS metrics are discussed in a separate paper. 7 While using the EMGbased movement-sensing system, the patient experienced an additional 8.2% of tremor while decreasing power usage by 53%, which is a 6.5% gain in power efficiency for every 1% of additional tremor. With the tremor-modulated system, the patient experienced much higher power savings of 84.5% at the cost of significant (36.2%) additional tremor, resulting in a 2.3% gain in power efficiency for every 1% increase in tremor.
Discussion
This case study demonstrates that the Activa PC+S system with cortical electrodes is a robust, fully implantable platform to research improving neuromodulation technologies for patients with movement disorders. Implanting both VIM and cortical electrodes in an ET patient opens up the ability to investigate the use of motor cortex signals for the purposes of creating a CLDBS system. We have begun our preliminary research using this system to sense movement intentions and have performed exploratory CLDBS experiments using wearable sensors to provide symptom feedback.
The results from our movement-prompting task, shown in Figs. 3 and 4 , show that overt movements are clearly distinguishable from rest given a broad movement-related beta-band desynchronization. 9 These beta-band changes correlate well temporally with inertial and EMG evidence of movement. However, our patient's imagined movements are much harder to distinguish, with a smaller desynchro- nization only noticeable between 26 and 36 Hz. This patient's beta band does not have the broad desynchronization during imagined movement, which has been seen in other literature. 13 The reason for this finding is unclear but possibly arises from patient difficulty in imagining movement.
The results from our preliminary CLDBS trials indicate that the patient's tremor can be reduced while receiving selective and dynamic stimulation. For this patient and these algorithms, the EMG-based movement-triggered system performed better during these trials than the IMU tremor-modulated system. This may be due to the inertial system's requirement that tremor be present to respond. Thus, it is expected that there will be additional tremor when compared with the open-loop or EMG movementtriggered case. For the EMG movement-triggering system, it is important to note that the patient can make movements that do not result in tremor but that the system will still trigger stimulation. Thus, the EMG movement-triggering algorithm can result in unneeded stimulation when used outside of the clinic. However, this may still provide a large enough reduction in stimulation power to be of benefit. Future work will examine the prediction of tremor and determining the optimal amount of stimulation to treat it in real time.
There are multiple considerations when moving forward from the paradigm described to a neural-triggered closed-loop system. For example, the external sensors we used have very little latency, with near instantaneous access to EMG and inertial sensing data, with high bandwidth rates and high sampling rates. Using the embedded sensing capabilities of the PC+S system will introduce latency given the need for communication with the device; likewise, limits in the bandwidth of such communication will impose conditions on the sampling rate. For example, because of hardware limitations, exploring known cortical markers in the gamma band (> 65 Hz) was not feasible during these experiments. How such considerations will impact the development of algorithms and control systems is difficult to predict. A simple threshold in total beta-power decrease over time, for instance, would be a straightforward method to trigger stimulation; alternatively, examination of higher-order interactions between electrodes may prove a more accurate but more computationally costly implementation. A forthcoming firmware update for the current system will allow for better telemetry and will likely make it possible to use the gamma band as a potential cortical marker. Importantly, the consideration of accuracy in stimulation should take into account that an algorithm with a low false-negative and a potentially high false-positive rate (that is, delivery of stimulation when needed and sometimes when not needed) is very likely to be superior to the current paradigm, in which the stimulator is on 100% of the time. 
